Mainline Instruments will distribute the Envision suite of dry eye treatments in the UK after it signed an agreement with InMode.
The Envision platform features non-surgical dry eye treatments that focusdelicate subdermal layers in the periorbital area; including Lumecca-I intense pulsed light; Forma-I thermal bipolar radiofrequency and Morpheus8 fractional skin treatment to stimulate the underlying layers of the dermis.
Jack Hawkins, managing director of Mainline Instruments, commented: ‘As awareness of dry eye increases, more of our customers are seeking advanced treatments beyond traditional drops and wipes. Partnering with InMode enables us to provide the Envision platform, a state-of-the-art solution to meet the growing demand for effective dry eye care.’
